Spinal Anaesthesia for Caesarean Section in Day-1 Dengue Patient
Yes, spinal anaesthesia can be safely performed now for this caesarean section in a day-1 dengue patient who is afebrile with a platelet count of 159 ×10⁹/L, as this platelet level is well above the minimum threshold of 75,000 ×10⁹/L recommended for neuraxial procedures in obstetric patients with normal platelet function. 1
Key Decision Points
Platelet Count Assessment
- The patient's platelet count of 159 ×10⁹/L exceeds all safety thresholds for neuraxial anaesthesia in obstetric patients 1
- Guidelines recommend a minimum platelet count of 75,000 ×10⁹/L for neuraxial procedures in obstetric populations, provided platelet function is expected to be normal 1
- The most recent 2025 ISTH consensus recommends platelet counts ≥75 ×10⁹/L for neuraxial anaesthesia in patients with platelet disorders and mild bleeding history 1
Dengue-Specific Considerations
- Dengue infection itself is NOT a contraindication to neuraxial anaesthesia 1
- The patient being afebrile on day 1 and having a platelet count of 159 ×10⁹/L indicates early, non-severe disease 2
- Routine indications and contraindications for neuraxial anaesthesia apply when managing dengue patients 1
Additional Safety Checks Required Before Proceeding
- Verify absence of coagulopathy by checking PT/INR and aPTT, as dengue can cause coagulation abnormalities independent of platelet count 2
- Confirm no clinical bleeding manifestations (petechiae, mucosal bleeding, hematuria) 3, 4
- Ensure no signs of severe dengue (plasma leakage, severe bleeding, organ impairment) 3
Why Neuraxial Anaesthesia is Preferred
Advantages Over General Anaesthesia
- Neuraxial anaesthesia should be the preferred technique for caesarean section to avoid risks of difficult intubation, pulmonary aspiration, and inferior postoperative analgesia associated with general anaesthesia in pregnant women 1
- General anaesthesia carries higher maternal risks in obstetric patients and should be reserved for situations with contraindications to neuraxial techniques 1
Evidence from Viral Infections
- Studies of obstetric patients with COVID-19 infection demonstrated safe neuraxial anaesthesia use with no contraindications, haemodynamic instability, or neurological complications in patients without thrombocytopenia or sepsis 1
- This experience with viral infections supports the safety of neuraxial techniques in dengue patients meeting platelet thresholds 1
Critical Monitoring Points
Intraoperative Management
- Be prepared to manage hypotension with vasopressors, as neuraxial anaesthesia can cause hypotension regardless of dengue status 1
- Use standard aseptic techniques as for non-dengue patients 1
- Avoid reducing spinal anaesthetic doses, as conversion to general anaesthesia is the least desirable outcome 1
Laboratory Surveillance
- Although conventional coagulation tests (PT, aPTT) are typically normal in dengue patients with thrombocytopenia, thromboelastometry studies show hypocoagulability in 71.7% of dengue patients despite normal standard tests 2
- This discrepancy suggests checking coagulation parameters before proceeding, even with adequate platelet counts 2
Common Pitfalls to Avoid
- Do not delay necessary caesarean section waiting for higher platelet counts when the current level (159 ×10⁹/L) is already safe 1
- Do not assume bleeding risk correlates directly with platelet count in dengue, as platelet counts do not correlate well with clinical bleeding 3
- Do not overlook coagulation abnormalities that may exist despite normal platelet counts in dengue patients 2
- Bleeding complications in dengue can occur at platelet counts up to 70,000/mm³, but this patient's count of 159,000/mm³ provides substantial safety margin 4
Contraindications That Would Change This Decision
Neuraxial anaesthesia should be deferred or avoided if: